Evaluation of a 5-day High-Dose Course of Amoxicillin for the Management of Community-Acquired Pneumonia in Children of 6 months to 10 years of Age

  22 October 2022

Community-acquired pneumonia (CAP) is one of the more frequently diagnosed infections in children. The Infectious Diseases Society of America (IDSA) does not currently recommend a specific duration of antibiotics for CAP but notes that 10-day courses are best studied. Studies in adults report that shorter durations can be just as effective. This study was a 2-center, blinded, noninferiority trial comparing 5 vs 10 days of high-dose amoxicillin for CAP.

 

Author(s): Torsten Joerger et al
Kids and Carers  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed